Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Eli Lilly $LLY said its experimental drug retatrutide helped patients with Type 2 diabetes shed up to 16.8% of their body weight over 40 weeks in a Phase 3 trial, outpacing all diabetes drugs now available.
This means if your research protocol calls for a 500mcg dose, you would draw up 5 units on the insulin syringe
Targeting the nlrp3 inflammasome in inflammatory diseases
These results reflect consistent dose amounts across manufacturing batches, controlled patient selection criteria, standardized administration protocols, and comprehensive monitoring of adverse events
US$ 27.43
US$ 26.26
US$ 28.30
US$ 29.42
